elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Daunorubicin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Daunorubicin
RIS
0.000
(Research Intensity Score)
Papers
107
Top papers
Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1- m or KMT2A -r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007
2024 · 32 citations
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach
2021 · 189 citations
A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis
2025 · 19 citations
Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterations
2025 · 10 citations
Exosomes-based dual drug-loaded nanocarrier for targeted and multiple proliferative vitreoretinopathy therapy
2024 · 20 citations
Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy
2023 · 29 citations
Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy
2025 · 8 citations
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
2022 · 48 citations
<p>A review of small molecules and drug delivery applications using gold and iron nanoparticles</p>
2019 · 220 citations
Newest papers
From signal to significance: characterizing anthracycline-related hypercoagulable adverse events via pharmacovigilance, animal models, and clinical observation
2026
Fabrication of hairpin DNA-functionalized polydopamine-coated gold nanoparticles as a theranostic nanoplatform for effective delivery of daunorubicin: Binding affinity, drug release and cytotoxicity study
2026 · 2 citations
Enhanced Cytotoxicity of Liposomal Daunorubicin in HCT116 Colorectal Cancer Cells: Modulation of Oxidative Stress and ERK1/2 gene expression
2026
A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis
2025 · 19 citations
Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterations
2025 · 10 citations
Human Mesenchymal Stem Cell-Derived Exosomes as Engineering Vehicles of Daunorubicin for Targeted c-Mpl+ AML Therapy
2025 · 8 citations
Phase 1 study of revumenib in combination with intensive chemotherapy (IC) in patients (Pts) with newly diagnosed (ND) Acute Myeloid Leukemia (AML) harboring genetic alterations in KMT2A, NPM1, or NUP98: SNDX-5613-0708
2025 · 4 citations
Single-cell sequencing reveals the impact of low-dose vs standard-dose chemotherapy and infection on lymphocytes in pediatric AML
2025
POSTER: AML-481 Treatment Outcomes of All-Trans Retinoic Acid, Arsenic Trioxide, and Daunorubicin in High-Risk Pediatric Acute Promyelocytic Leukemia: A Single-Center Study From a Quaternary Care Center in South India
2025
Browse all papers →
Daunorubicin's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Daunorubicin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link